227 related articles for article (PubMed ID: 21946258)
1. Phospholipase A(2)-susceptible liposomes of anticancer double lipid-prodrugs.
Arouri A; Mouritsen OG
Eur J Pharm Sci; 2012 Mar; 45(4):408-20. PubMed ID: 21946258
[TBL] [Abstract][Full Text] [Related]
2. Anticancer double lipid prodrugs: liposomal preparation and characterization.
Arouri A; Mouritsen OG
J Liposome Res; 2011 Dec; 21(4):296-305. PubMed ID: 21438721
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic action of phospholipase A₂ on liposomal drug delivery systems.
Hansen AH; Mouritsen OG; Arouri A
Int J Pharm; 2015 Aug; 491(1-2):49-57. PubMed ID: 26056930
[TBL] [Abstract][Full Text] [Related]
5. Liposomal formulation of retinoids designed for enzyme triggered release.
Pedersen PJ; Adolph SK; Subramanian AK; Arouri A; Andresen TL; Mouritsen OG; Madsen R; Madsen MW; Peters GH; Clausen MH
J Med Chem; 2010 May; 53(9):3782-92. PubMed ID: 20405849
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biophysical characterization of chlorambucil anticancer ether lipid prodrugs.
Pedersen PJ; Christensen MS; Ruysschaert T; Linderoth L; Andresen TL; Melander F; Mouritsen OG; Madsen R; Clausen MH
J Med Chem; 2009 May; 52(10):3408-15. PubMed ID: 19402667
[TBL] [Abstract][Full Text] [Related]
7. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
[TBL] [Abstract][Full Text] [Related]
8. Liposomes as carriers for colchicine-derived prodrugs: vascular disrupting nanomedicines with tailorable drug release kinetics.
Crielaard BJ; van der Wal S; Le HT; Bode AT; Lammers T; Hennink WE; Schiffelers RM; Fens MH; Storm G
Eur J Pharm Sci; 2012 Mar; 45(4):429-35. PubMed ID: 21907797
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic study of the sPLA2-mediated hydrolysis of a thio-ester pro anticancer ether lipid.
Linderoth L; Fristrup P; Hansen M; Melander F; Madsen R; Andresen TL; Peters GH
J Am Chem Soc; 2009 Sep; 131(34):12193-200. PubMed ID: 19663381
[TBL] [Abstract][Full Text] [Related]
10. Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids.
Jensen SS; Andresen TL; Davidsen J; Høyrup P; Shnyder SD; Bibby MC; Gill JH; Jørgensen K
Mol Cancer Ther; 2004 Nov; 3(11):1451-8. PubMed ID: 15542784
[TBL] [Abstract][Full Text] [Related]
11. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release.
Lindner LH; Hossann M; Vogeser M; Teichert N; Wachholz K; Eibl H; Hiddemann W; Issels RD
J Control Release; 2008 Jan; 125(2):112-20. PubMed ID: 18022271
[TBL] [Abstract][Full Text] [Related]
12. Generation of fatty acids from 1,2-dipalmitoyl-sn-glycero-3-phosphocholine/cardiolipin liposomes that stabilize recombinant human serum albumin.
Frahm GE; Cameron BE; Smith JC; Johnston MJ
J Liposome Res; 2013 Jun; 23(2):101-9. PubMed ID: 23294393
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery by an enzyme-mediated cyclization of a lipid prodrug with unique bilayer-formation properties.
Linderoth L; Peters GH; Madsen R; Andresen TL
Angew Chem Int Ed Engl; 2009; 48(10):1823-6. PubMed ID: 19173369
[TBL] [Abstract][Full Text] [Related]
14. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system.
Tagami T; Ernsting MJ; Li SD
J Control Release; 2011 Sep; 154(3):290-7. PubMed ID: 21640149
[TBL] [Abstract][Full Text] [Related]
15. Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery.
Kaasgaard T; Andresen TL; Jensen SS; Holte RO; Jensen LT; Jørgensen K
Chem Phys Lipids; 2009 Feb; 157(2):94-103. PubMed ID: 19094974
[TBL] [Abstract][Full Text] [Related]
16. Effect of fatty acids on the permeability barrier of model and biological membranes.
Arouri A; Lauritsen KE; Nielsen HL; Mouritsen OG
Chem Phys Lipids; 2016 Oct; 200():139-146. PubMed ID: 27725161
[TBL] [Abstract][Full Text] [Related]
17. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
18. Lipids, curvature stress, and the action of lipid prodrugs: free fatty acids and lysolipid enhancement of drug transport across liposomal membranes.
Jespersen H; Andersen JH; Ditzel HJ; Mouritsen OG
Biochimie; 2012 Jan; 94(1):2-10. PubMed ID: 21839138
[TBL] [Abstract][Full Text] [Related]
19. Effects of lipid chain unsaturation and headgroup type on molecular interactions between paclitaxel and phospholipid within model biomembrane.
Zhao L; Feng SS
J Colloid Interface Sci; 2005 May; 285(1):326-35. PubMed ID: 15797430
[TBL] [Abstract][Full Text] [Related]
20. Labdane-type diterpenes: thermal effects on phospholipid bilayers, incorporation into liposomes and biological activity.
Matsingou C; Hatziantoniou S; Georgopoulos A; Dimas K; Terzis A; Demetzos C
Chem Phys Lipids; 2005 Dec; 138(1-2):1-11. PubMed ID: 16182267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
